Patients in the recurrence group showed increased expression of TLR1, TLR6 and TLR8 receptors, so that NOD‐like and TNFα signaling were increased (protective CML microenvironment) [22]. Here, TNF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.